Table 4.
N | 5-Year OS (SE) |
5-Year DSS (SE) |
5-Year LRFS (SE) | 5-Year DMFS (SE) | |
---|---|---|---|---|---|
All patients | 64 * | 78.4% (6.7) | 89% (4.9) | 92.5% (3.6) | 87.1% (4.5) |
OS: overall survival; DSS: disease-specific survival; LRFS: local relapse-free survival; DMFS: distant metastasis-free survival; SE: standard error. * The patient treated for bilateral lesions was evaluated on the basis of the risk factors for the first lesion.